<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01751971</url>
  </required_header>
  <id_info>
    <org_study_id>2005P001296-O2PSG</org_study_id>
    <secondary_id>R01HL090897</secondary_id>
    <nct_id>NCT01751971</nct_id>
  </id_info>
  <brief_title>Estimating Apnea Phenotypes From Polysomnography: Oxygen</brief_title>
  <acronym>PSGtraits-O2</acronym>
  <official_title>Estimating Apnea Phenotypes From Routine Polysomnography: Application to Oxygen Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to employ advanced methods to estimate the individual factors contributing
      to sleep apnea from standard recordings made during routine clinical sleep studies. This
      study focuses on breathing control or &quot;loop gain&quot; as one of the factors contributing to sleep
      apnea. Increased levels of oxygen in the air is known to make breathing more stable by
      lowering &quot;loop gain&quot;. Here, our goal is to use a new method capable of detecting a reduction
      in loop gain with oxygen. The investigators also aim to test whether a high loop gain
      measured at baseline/placebo predicts a greater improvement in sleep apnea with oxygen
      therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a single-blinded randomized crossover study, inspired oxygen/air (40%/21%) is delivered on
      two separate nights. Loop gain is measured from routine polysomnography using a novel
      mathematical method. A value of loop gain &gt;1 reflects unstable breathing, and a value less
      than but approaching 1 denotes a system more prone to oscillate. Loop gain is measured as the
      changes in ventilatory drive/effort that arises subsequent to changes in ventilation (e.g.
      due to obstructive apnea). A simple chemoreflex model (gain, time constant, delay) is fit to
      surrogate ventilation data (derived from airflow) during sleep. The best model is one that
      best matches the elevated ventilatory drive (measured as ventilation in the absence of
      airflow obstruction) based on the prior apneic/hypopneic fall in ventilation. Loop gain is
      calculated from this model. We aim to use loop gain measured on and off oxygen to determine
      whether a strong response (reduction in apnea severity) can be predicted by a higher loop
      gain (in the sham arm) using our method. We also assessed whether assessing upper airway
      anatomy/collapsibility, dilator muscle responsiveness, and the arousal threshold helped to
      predict responses to treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants were not informed whether they were breathing supplemental inspired oxygen or sham (air) on the study night. Technicians and investigators performing the study were not masked in order to carefully ensure delivery of treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-hypopnea Index</measure>
    <time_frame>1 night</time_frame>
    <description>Apnea-hypopnea index (AHI) will be compared between oxygen and sham nights. Hypopneas are based on 30% reduction in airflow (no desaturation or arousal criteria). AHI data are exclusive to non-REM supine sleep.
The results presented here are for the AHI at each intervention (&quot;per intervention&quot;) regardless of the sequence (preferred clinicaltrials.gov format).
Please note, however, that the a priori outcome measure was the reduction in AHI with oxygen as a percent of sham values, i.e. (AHI on sham - AHI on oxygen)/(AHI on sham) % (a comparison with greater statistical power), compared between patient subgroups (see Statistical Analysis section).
Subgroups were defined a priori as higher (&gt;=0.7) versus lower loop gain (&lt;0.7), but tests were also performed in subgroups defined by &quot;favorable&quot; versus &quot;unfavorable&quot; pathophysiology.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of EEG Arousals (Events Per Hour)</measure>
    <time_frame>1 night</time_frame>
    <description>Frequency of scored EEG arousals per hour of non-REM sleep. Note: Our objective was to describe changes in secondary outcomes within phenotypic subgroups. Overall effects (unselected patients / ignoring phenotypic subgroups) are first presented below, followed by effects in favorable vs. unfavorable subgroups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overnight Change in Systolic Blood Pressure</measure>
    <time_frame>1 night</time_frame>
    <description>The change in systolic blood pressure overnight. Two supine oscillometric measurements of blood pressure are made: just prior to lights out (evening), and after lights on (morning).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overnight Change in Diastolic Blood Pressure</measure>
    <time_frame>1 night</time_frame>
    <description>The change in diastolic blood pressure overnight. Two supine oscillometric measurements of blood pressure are made: just prior to lights out (evening), and after lights on (morning).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Sleep Quality (Oxygen vs Sham)</measure>
    <time_frame>1 night</time_frame>
    <description>Better(+1)/Same(0)/Worse(-1) on oxygen vs sham, i.e. &quot;a relative comparison between arms&quot;. When subjects had completed the entire study, they were asked to compare subjectively their sleep quality on the first versus second study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Sleepiness/Alertness (Stanford Sleepiness Scale)</measure>
    <time_frame>1 night</time_frame>
    <description>Assessed in the morning after the single night of treatment. Minimum score: 1 (alert), maximum score: 7 (not alert).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Inspired Oxygen First</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants breathe air with additional inspired oxygen (40%) for 1 night during an overnight sleep study (15 L/min via venturi mask). 1 week later participants will crossover to Sham (sham comparator).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham First</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants breathe air without additional inspired oxygen for 1 night during sleep (15 L/min via Venturi mask). 1 week later participants will crossover to Inspire Oxygen (active intervention).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inspired oxygen (40%)</intervention_name>
    <description>Supplemental oxygen at 40% inspired via venturi mask (15 L/min). Equivalent to 5 L/min via nasal cannula.</description>
    <arm_group_label>Inspired Oxygen First</arm_group_label>
    <arm_group_label>Sham First</arm_group_label>
    <other_name>Supplemental oxygen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Medical air with 21% oxygen via venturi mask (15 L/min).</description>
    <arm_group_label>Inspired Oxygen First</arm_group_label>
    <arm_group_label>Sham First</arm_group_label>
    <other_name>Medical air</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apnea/hypopnea index &gt;20 events per hour

          -  Age 20-79 years

        Exclusion Criteria:

          -  COPD with desaturation (resting SpO2&lt;96%)

          -  Use of respiratory stimulants or depressants

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SCOTT A Sands, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2012</study_first_submitted>
  <study_first_submitted_qc>December 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2012</study_first_posted>
  <results_first_submitted>May 19, 2017</results_first_submitted>
  <results_first_submitted_qc>December 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">January 8, 2018</results_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Scott Aaron Sands</investigator_full_name>
    <investigator_title>Instructor in Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Oxygen First</title>
          <description>Participants participate in inspired oxygen arm (40% oxygen) first, then the air night (21% oxygen) second
Inspired oxygen (40%): Supplemental oxygen at approximately 40% e.g. via Pink venturi mask</description>
        </group>
        <group group_id="P2">
          <title>Air First</title>
          <description>Participants participate in the air night (sham) first, then the oxygen night second.
Sham: Medical air with 21% oxygen e.g. via Pink venturi mask</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oxygen First</title>
          <description>Participants participate in inspired oxygen arm (40% oxygen) first, then the air night (21% oxygen) second
Inspired oxygen (40%): Supplemental oxygen at approximately 40% e.g. via Pink venturi mask</description>
        </group>
        <group group_id="B2">
          <title>Air First</title>
          <description>Participants participate in the air night (sham) first, then the oxygen night second.
Sham: Medical air with 21% oxygen e.g. via Pink venturi mask</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="47"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" spread="13"/>
                    <measurement group_id="B2" value="49" spread="22"/>
                    <measurement group_id="B3" value="52" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Apnea-hypopnea Index</title>
        <description>Apnea-hypopnea index (AHI) will be compared between oxygen and sham nights. Hypopneas are based on 30% reduction in airflow (no desaturation or arousal criteria). AHI data are exclusive to non-REM supine sleep.
The results presented here are for the AHI at each intervention (&quot;per intervention&quot;) regardless of the sequence (preferred clinicaltrials.gov format).
Please note, however, that the a priori outcome measure was the reduction in AHI with oxygen as a percent of sham values, i.e. (AHI on sham - AHI on oxygen)/(AHI on sham) % (a comparison with greater statistical power), compared between patient subgroups (see Statistical Analysis section).
Subgroups were defined a priori as higher (&gt;=0.7) versus lower loop gain (&lt;0.7), but tests were also performed in subgroups defined by &quot;favorable&quot; versus &quot;unfavorable&quot; pathophysiology.</description>
        <time_frame>1 night</time_frame>
        <population>Patients with AHI&gt;20</population>
        <group_list>
          <group group_id="O1">
            <title>Inspired Oxygen</title>
            <description>Inspired oxygen (40%) for 1 night via venturi mask.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Sham: Medical air with 21% oxygen via venturi mask</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea-hypopnea Index</title>
          <description>Apnea-hypopnea index (AHI) will be compared between oxygen and sham nights. Hypopneas are based on 30% reduction in airflow (no desaturation or arousal criteria). AHI data are exclusive to non-REM supine sleep.
The results presented here are for the AHI at each intervention (&quot;per intervention&quot;) regardless of the sequence (preferred clinicaltrials.gov format).
Please note, however, that the a priori outcome measure was the reduction in AHI with oxygen as a percent of sham values, i.e. (AHI on sham - AHI on oxygen)/(AHI on sham) % (a comparison with greater statistical power), compared between patient subgroups (see Statistical Analysis section).
Subgroups were defined a priori as higher (&gt;=0.7) versus lower loop gain (&lt;0.7), but tests were also performed in subgroups defined by &quot;favorable&quot; versus &quot;unfavorable&quot; pathophysiology.</description>
          <population>Patients with AHI&gt;20</population>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.5" spread="3.8"/>
                    <measurement group_id="O2" value="57.9" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with high loop gain (LG1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.5" spread="6.4"/>
                    <measurement group_id="O2" value="74.3" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with low loop gain (LG1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.9" spread="4.6"/>
                    <measurement group_id="O2" value="48.5" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with favorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5" spread="4.3"/>
                    <measurement group_id="O2" value="49.5" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with unfavorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.9" spread="4.1"/>
                    <measurement group_id="O2" value="63.2" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Primary statistical comparison was the percent reduction in AHI----[AHI(sham)-AHI(oxygen)]/AHI(sham) %----between two phenotypic patient subgroups. Patient subgroups were defined by the loop gain (LG1) measured on the sham night as &quot;high&quot; or &quot;low&quot; (a priori cutoff LG1=0.7).</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>10.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-16</ci_lower_limit>
            <ci_upper_limit>37.1</ci_upper_limit>
            <estimate_desc>Positive estimated value would represent a greater reduction in AHI with oxygen (% sham) in the high vs low loop gain group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Here we aimed to confirm that there was a difference between AHI on oxygen vs sham (overall, i.e. in unselected patients). This test, however was not part of our primary objective.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>17.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>10.7</ci_lower_limit>
            <ci_upper_limit>24.1</ci_upper_limit>
            <estimate_desc>Direction of comparison: Positive estimation parameter would indicate lower AHI on oxygen versus sham.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The primary goal of the study was to identify a phenotypic subgroup of patients with sleep apnea that responds preferentially to oxygen (percent reduction in AHI----[AHI(sham)-AHI(oxygen)]/AHI(sham) %). We defined patient subgroups (&quot;favorable&quot; versus &quot;unfavorable&quot;) based on the four key phenotypic traits (loop gain, collapsibility, arousal threshold, muscle responses) measured on the sham night, with the use of multiple logistic regression and leave-one-out cross validation.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>42.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>21.0</ci_lower_limit>
            <ci_upper_limit>64.6</ci_upper_limit>
            <estimate_desc>Direction of comparison: Positive estimated value would indicate a greater percentage reduction in AHI (oxygen vs. sham) in favorable vs. unfavorable subgroups.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of EEG Arousals (Events Per Hour)</title>
        <description>Frequency of scored EEG arousals per hour of non-REM sleep. Note: Our objective was to describe changes in secondary outcomes within phenotypic subgroups. Overall effects (unselected patients / ignoring phenotypic subgroups) are first presented below, followed by effects in favorable vs. unfavorable subgroups.</description>
        <time_frame>1 night</time_frame>
        <population>Patients with AHI&gt;20</population>
        <group_list>
          <group group_id="O1">
            <title>Inspired Oxygen</title>
            <description>Inspired oxygen (40%): Supplemental oxygen at approximately 40% e.g. via Pink venturi mask</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Sham: Medical air with 21% oxygen e.g. via Pink venturi mask</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of EEG Arousals (Events Per Hour)</title>
          <description>Frequency of scored EEG arousals per hour of non-REM sleep. Note: Our objective was to describe changes in secondary outcomes within phenotypic subgroups. Overall effects (unselected patients / ignoring phenotypic subgroups) are first presented below, followed by effects in favorable vs. unfavorable subgroups.</description>
          <population>Patients with AHI&gt;20</population>
          <units>events/hr</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.9" spread="3.4"/>
                    <measurement group_id="O2" value="50.3" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with favorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.8" spread="3.0"/>
                    <measurement group_id="O2" value="39.7" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with unfavorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.4" spread="4.1"/>
                    <measurement group_id="O2" value="57.0" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overnight Change in Systolic Blood Pressure</title>
        <description>The change in systolic blood pressure overnight. Two supine oscillometric measurements of blood pressure are made: just prior to lights out (evening), and after lights on (morning).</description>
        <time_frame>1 night</time_frame>
        <population>Patients with AHI&gt;20</population>
        <group_list>
          <group group_id="O1">
            <title>Inspired Oxygen</title>
            <description>Inspired oxygen (40%): Supplemental oxygen at approximately 40% e.g. via Pink venturi mask</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Sham: Medical air with 21% oxygen e.g. via Pink venturi mask</description>
          </group>
        </group_list>
        <measure>
          <title>Overnight Change in Systolic Blood Pressure</title>
          <description>The change in systolic blood pressure overnight. Two supine oscillometric measurements of blood pressure are made: just prior to lights out (evening), and after lights on (morning).</description>
          <population>Patients with AHI&gt;20</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.4"/>
                    <measurement group_id="O2" value="3.0" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with favorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.9"/>
                    <measurement group_id="O2" value="3.4" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with unfavorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="1.9"/>
                    <measurement group_id="O2" value="2.8" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overnight Change in Diastolic Blood Pressure</title>
        <description>The change in diastolic blood pressure overnight. Two supine oscillometric measurements of blood pressure are made: just prior to lights out (evening), and after lights on (morning).</description>
        <time_frame>1 night</time_frame>
        <population>Patients with AHI&gt;20</population>
        <group_list>
          <group group_id="O1">
            <title>Inspired Oxygen</title>
            <description>Inspired oxygen (40%) for 1 night via venturi mask. &quot;Arm&quot; here is defined as the Oxygen Intervention. 18 participants participated in inspired oxygen arm (40% oxygen) first, then the air night (21% oxygen) second. 18 participants participated in the other order.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Sham: Medical air with 21% oxygen e.g. via Pink venturi mask &quot;Arm&quot; here is defined as the Sham Intervention. 18 participants participated in inspired oxygen arm (40% oxygen) first, then the air night (21% oxygen) second. 18 participants participated in the other order.</description>
          </group>
        </group_list>
        <measure>
          <title>Overnight Change in Diastolic Blood Pressure</title>
          <description>The change in diastolic blood pressure overnight. Two supine oscillometric measurements of blood pressure are made: just prior to lights out (evening), and after lights on (morning).</description>
          <population>Patients with AHI&gt;20</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.9"/>
                    <measurement group_id="O2" value="4.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with favorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.2"/>
                    <measurement group_id="O2" value="6.4" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with unfavorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="1.2"/>
                    <measurement group_id="O2" value="2.5" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Sleep Quality (Oxygen vs Sham)</title>
        <description>Better(+1)/Same(0)/Worse(-1) on oxygen vs sham, i.e. &quot;a relative comparison between arms&quot;. When subjects had completed the entire study, they were asked to compare subjectively their sleep quality on the first versus second study.</description>
        <time_frame>1 night</time_frame>
        <population>Patients with AHI&gt;20. One patient, whose treatment and sham nights were separated by an extended duration (due to scheduling), did not provide data for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>All Participants</title>
            <description>Data are presented as a single arm because results are inherently a comparison between arms. Participants were asked to rate whether their sleep quality was better/same/worse on study night 2 versus study night 1. Data are presented in terms of better/same/worse on oxygen compared to sham.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Sleep Quality (Oxygen vs Sham)</title>
          <description>Better(+1)/Same(0)/Worse(-1) on oxygen vs sham, i.e. &quot;a relative comparison between arms&quot;. When subjects had completed the entire study, they were asked to compare subjectively their sleep quality on the first versus second study.</description>
          <population>Patients with AHI&gt;20. One patient, whose treatment and sham nights were separated by an extended duration (due to scheduling), did not provide data for this outcome measure.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with favorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with unfavorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Sleepiness/Alertness (Stanford Sleepiness Scale)</title>
        <description>Assessed in the morning after the single night of treatment. Minimum score: 1 (alert), maximum score: 7 (not alert).</description>
        <time_frame>1 night</time_frame>
        <population>Patients with AHI&gt;20</population>
        <group_list>
          <group group_id="O1">
            <title>Inspired Oxygen</title>
            <description>Inspired oxygen (40%) via Pink venturi mask</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>Sham: Medical air with 21% oxygen e.g. via Pink venturi mask</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Sleepiness/Alertness (Stanford Sleepiness Scale)</title>
          <description>Assessed in the morning after the single night of treatment. Minimum score: 1 (alert), maximum score: 7 (not alert).</description>
          <population>Patients with AHI&gt;20</population>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All patients</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="0.19"/>
                    <measurement group_id="O2" value="2.03" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with favorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.14" spread="0.32"/>
                    <measurement group_id="O2" value="2.11" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with unfavorable pathophysiology</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.13" spread="0.25"/>
                    <measurement group_id="O2" value="1.99" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Inspired Oxygen</title>
          <description>Inspired Oxygen 40%</description>
        </group>
        <group group_id="E2">
          <title>Sham</title>
          <description>Sham, room air</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Scott Sands, PhD</name_or_title>
      <organization>Brigham and Women's Hospital</organization>
      <phone>6172780911</phone>
      <email>sasands@bwh.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

